Jeffrey P. North

Dr. Jeffrey P. North

orcid

Research Focus & Metrics

Academic Career Length

19Years (2008-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
17 October 2011 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Closed access
PDF file
NWNicholas J. Wang
Nicholas J. Wang
ZSZachary Sanborn
Zachary Sanborn
KAKelly L. Arnett
Kelly L. Arnett
LBLaura J. Bayston
Laura J. Bayston
WLWilson Liao
Wilson Liao
RCRaymond J. Cho
Raymond J. Cho
Squamous cell carcinomas (SCCs) are one of the most frequent forms of human malignancy, but, other than TP53 mutations, few causative somatic aberrations have been identified. We identified NOTCH1 or NOTCH2 mutations in ∼75% of cutaneous SCCs and in a lesser fraction of lung SCCs, defining a spectrum for the most prevalent tumor suppressor specific to these epithelial malignancies. Notch receptors normally transduce signals in response to ligands on neighboring cells, regulating metazoan lineage selection and developmental patterning. Our findings therefore illustrate a central role for disruption of microenvironmental communication in cancer progression. NOTCH aberrations include frameshift and nonsense mutations leading to receptor truncations as well as point substitutions in key functional domains that abrogate signaling in cell-based assays. Oncogenic gain-of-function mutations in NOTCH1 commonly occur in human T-cell lymphoblastic leukemia/lymphoma and B-cell chronic lymphocytic leukemia. The bifunctional role of Notch in human cancer thus emphasizes the context dependency of signaling outcomes and suggests that targeted inhibition of the Notch pathway may induce squamous epithelial malignancies.

15 April 2022 in Science Immunology
Verified
Journal Article
Closed access
YLYale Liu
Yale Liu
HWHao Wang
Hao Wang
MTMark Taylor
Mark Taylor
CCChristopher Cook
Christopher Cook
AMAlejandra Martínez-Berdeja
Alejandra Martínez-Berdeja
JCJeffrey B. Cheng
Jeffrey B. Cheng
Inflammatory conditions represent the largest class of chronic skin disease, but the molecular dysregulation underlying many individual cases remains unclear. Single-cell RNA sequencing (scRNA-seq) has increased precision in dissecting the complex mixture of immune and stromal cell perturbations in inflammatory skin disease states. We single-cell–profiled CD45 + immune cell transcriptomes from skin samples of 31 patients (7 atopic dermatitis, 8 psoriasis vulgaris, 2 lichen planus (LP), 1 bullous pemphigoid (BP), 6 clinical/histopathologically indeterminate rashes, and 7 healthy controls). Our data revealed active proliferative expansion of the T reg and Trm components and universal T cell exhaustion in human rashes, with a relative attenuation of antigen-presenting cells. Skin-resident memory T cells showed the greatest transcriptional dysregulation in both atopic dermatitis and psoriasis, whereas atopic dermatitis also demonstrated recurrent abnormalities in ILC and CD8 + cytotoxic lymphocytes. Transcript signatures differentiating these rash types included genes previously implicated in T helper cell (T H 2)/T H 17 diatheses, segregated in unbiased functional networks, and accurately identified disease class in untrained validation data sets. These gene signatures were able to classify clinicopathologically ambiguous rashes with diagnoses consistent with therapeutic response. Thus, we have defined major classes of human inflammatory skin disease at the molecular level and described a quantitative method to classify indeterminate instances of pathologic inflammation. To make this approach accessible to the scientific community, we created a proof-of-principle web interface (RashX), where scientists and clinicians can visualize their patient-level rash scRNA-seq–derived data in the context of our T H 2/T H 17 transcriptional framework.

1 August 2008 in Journal of Investigative Dermatology
Verified
Journal Article
Closed access
PDF file
Jeffrey P. NorthJeffrey P. North
Jeffrey P. North
TKToshiro Kageshita
Toshiro Kageshita
DPDaniel Pinkel
Daniel Pinkel
PLPhilip E. LeBoit
Philip E. LeBoit
BBBoris C. Bastian
Boris C. Bastian

14 May 2018 in Nature Communications
Verified
Journal Article
Open access
PDF file
Jeffrey P. NorthJeffrey P. North
Jeffrey P. North
JGJustin Golovato
Justin Golovato
CVCharles J. Vaske
Charles J. Vaske
JSJ. Zachary Sanborn
J. Zachary Sanborn
ANAndrew Nguyen
Andrew Nguyen
RCRaymond J. Cho
Raymond J. Cho
Sebaceous carcinomas (SeC) are cutaneous malignancies that, in rare cases, metastasize and prove fatal. Here we report whole-exome sequencing on 32 SeC, revealing distinct mutational classes that explain both cancer ontogeny and clinical course. A UV-damage signature predominates in 10/32 samples, while nine show microsatellite instability (MSI) profiles. UV-damage SeC exhibited poorly differentiated, infiltrative histopathology compared to MSI signature SeC (p = 0.003), features previously associated with dissemination. Moreover, UV-damage SeC transcriptomes and anatomic distribution closely resemble those of cutaneous squamous cell carcinomas (SCC), implicating sun-exposed keratinocytes as a cell of origin. Like SCC, this UV-damage subclass harbors a high somatic mutation burden with >50 mutations per Mb, predicting immunotherapeutic response. In contrast, ocular SeC acquires far fewer mutations without a dominant signature, but show frequent truncations in the ZNF750 epidermal differentiation regulator. Our data exemplify how different mutational processes convergently drive histopathologically related but clinically distinct cancers.

1 November 2013 in Journal of the American Academy of Dermatology
Verified
Journal Article
Closed access
RRRoss B. Reule
Ross B. Reule
Jeffrey P. NorthJeffrey P. North
Jeffrey P. North

1 October 2020 in iScience
Verified
Journal Article
Open access
YLYale Liu
Yale Liu
CCChristopher Cook
Christopher Cook
ASAndrew J. Sedgewick
Andrew J. Sedgewick
SZShuyi Zhang
Shuyi Zhang
MFMarlys S. Fassett
Marlys S. Fassett
JCJeffrey B. Cheng
Jeffrey B. Cheng
Inflammatory response heterogeneity has impeded high-resolution dissection of diverse immune cell populations during activation. We characterize mouse cutaneous immune cells by single-cell RNA sequencing, after inducing inflammation using imiquimod and oxazolone dermatitis models. We identify 13 CD45+ subpopulations, which broadly represent most functionally characterized immune cell types. Oxazolone pervasively upregulates Jak2/Stat3 expression across T cells and antigen-presenting cells (APCs). Oxazolone also induces Il4/Il13 expression in newly infiltrating basophils, and Il4ra and Ccl24, most prominently in APCs. In contrast, imiquimod broadly upregulates Il17/Il22 and Ccl4/Ccl5. A comparative analysis of single-cell inflammatory transcriptional responses reveals that APC response to oxazolone is tightly restricted by cell identity, whereas imiquimod enforces shared programs on multiple APC populations in parallel. These global molecular patterns not only contrast immune responses on a systems level but also suggest that the mechanisms of new sources of inflammation can eventually be deduced by comparison to known signatures.